NEUROTOXICITY
Clinical trials for NEUROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new NEUROTOXICITY trials appear
Sign up with your email to follow new studies for NEUROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to tame CAR-T's dangerous brain side effects
Disease control CompletedThis study tested whether adding a drug called anakinra to a powerful cell therapy (CAR-T) could reduce severe brain-related side effects in patients with lymphoma that has returned or resisted treatment. The main goal was to see if this combination made the CAR-T treatment safer…
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
ED drug may shield cancer patients from Chemo's painful side effect
Prevention CompletedThis study tested if tadalafil, a medication also used for erectile dysfunction, could prevent nerve damage caused by a common prostate cancer chemotherapy. Researchers gave 90 men with advanced prostate cancer either tadalafil or standard care alongside their chemotherapy. They …
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC